{"id":"https://openalex.org/W7220848616","doi":"https://doi.org/10.3389/fimmu.2026.1906981","title":"Clinical study of eculizumab with or with not tacrolimus in the treatment of generalized myasthenia gravis","display_name":"Clinical study of eculizumab with or with not tacrolimus in the treatment of generalized myasthenia gravis","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220848616","doi":"https://doi.org/10.3389/fimmu.2026.1906981","pmid":"https://pubmed.ncbi.nlm.nih.gov/42908923","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13683607"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1906981","doi":"https://doi.org/10.3389/fimmu.2026.1906981","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1906981","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1906981/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1906981/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157871054","display_name":"Bin Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99065089","display_name":"Tsinghua University","ror":"https://ror.org/03cve4549","country_code":"CN","type":"education","lineage":["https://openalex.org/I99065089"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bin Yang","raw_affiliation_strings":["Department of Neurology, Tsinghua University Yuquan Hospital","School of Clinical Medicine, Tsinghua University School of Clinical Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Tsinghua University Yuquan Hospital","institution_ids":["https://openalex.org/I99065089"]},{"raw_affiliation_string":"School of Clinical Medicine, Tsinghua University School of Clinical Medicine","institution_ids":["https://openalex.org/I99065089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157870705","display_name":"Jing Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99065089","display_name":"Tsinghua University","ror":"https://ror.org/03cve4549","country_code":"CN","type":"education","lineage":["https://openalex.org/I99065089"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["Department of Neurology, Tsinghua University Yuquan Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Tsinghua University Yuquan Hospital","institution_ids":["https://openalex.org/I99065089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071784820","display_name":"\u8d75\u79c0\u4e3d","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99065089","display_name":"Tsinghua University","ror":"https://ror.org/03cve4549","country_code":"CN","type":"education","lineage":["https://openalex.org/I99065089"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiuli Zhao","raw_affiliation_strings":["Department of Neurology, Tsinghua University Yuquan Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Tsinghua University Yuquan Hospital","institution_ids":["https://openalex.org/I99065089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157804988","display_name":"Chuya Jing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99065089","display_name":"Tsinghua University","ror":"https://ror.org/03cve4549","country_code":"CN","type":"education","lineage":["https://openalex.org/I99065089"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chuya Jing","raw_affiliation_strings":["Department of Neurology, Tsinghua University Yuquan Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Tsinghua University Yuquan Hospital","institution_ids":["https://openalex.org/I99065089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101054234","display_name":"Jian Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119648","display_name":"Beijing Hospital","ror":"https://ror.org/02jwb5s28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210119648"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jian Yin","raw_affiliation_strings":["Department of Neurology, Beijing Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Beijing Hospital","institution_ids":["https://openalex.org/I4210119648"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5157846882","display_name":"Liyan Qiao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99065089","display_name":"Tsinghua University","ror":"https://ror.org/03cve4549","country_code":"CN","type":"education","lineage":["https://openalex.org/I99065089"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Liyan Qiao","raw_affiliation_strings":["Department of Neurology, Tsinghua University Yuquan Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Tsinghua University Yuquan Hospital","institution_ids":["https://openalex.org/I99065089"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5101054234","https://openalex.org/A5157846882"],"corresponding_institution_ids":["https://openalex.org/I4210119648","https://openalex.org/I99065089"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75093822,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1906981","last_page":"1906981"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/generalized-myasthenia-gravis","display_name":"generalized myasthenia gravis","score":0.9290000200271606},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":1.0},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":1.0},{"id":"https://openalex.org/keywords/complement-inhibition","display_name":"complement inhibition","score":0.7889999747276306},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.8169999718666077},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6370000243186951},{"id":"https://openalex.org/keywords/prednisolone-dose-reduction","display_name":"prednisolone dose reduction","score":0.7390000224113464},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.5460000038146973},{"id":"https://openalex.org/keywords/disability-outcome","display_name":"disability outcome","score":0.4000000059604645},{"id":"https://openalex.org/keywords/quantitative-myasthenia-gravis-score","display_name":"quantitative myasthenia gravis score","score":0.7739999890327454},{"id":"https://openalex.org/keywords/activities-of-daily-living","display_name":"activities of daily living","score":0.753000020980835},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.989799976348877},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8654999732971191},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.7613000273704529},{"id":"https://openalex.org/C2778105408","wikidata":"https://www.wikidata.org/wiki/Q8285","display_name":"Myasthenia gravis","level":2,"score":0.758899986743927},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.5612999796867371},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4758000075817108},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.4564000070095062},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.45210000872612},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.3984000086784363},{"id":"https://openalex.org/C2778842783","wikidata":"https://www.wikidata.org/wiki/Q603502","display_name":"Plasmapheresis","level":3,"score":0.35899999737739563},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3441999852657318},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.34040001034736633},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3345000147819519},{"id":"https://openalex.org/C54847362","wikidata":"https://www.wikidata.org/wiki/Q177635","display_name":"Nephrology","level":2,"score":0.2937999963760376},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28780001401901245},{"id":"https://openalex.org/C112313634","wikidata":"https://www.wikidata.org/wiki/Q7886648","display_name":"Complement (music)","level":5,"score":0.2703999876976013},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2597000002861023},{"id":"https://openalex.org/C2779901103","wikidata":"https://www.wikidata.org/wiki/Q419472","display_name":"Pyridostigmine","level":3,"score":0.25839999318122864},{"id":"https://openalex.org/C2992053201","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Clinical efficacy","level":2,"score":0.2500999867916107}],"mesh":[{"descriptor_ui":"D000203","descriptor_name":"Activities of Daily Living","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009157","descriptor_name":"Myasthenia Gravis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009157","descriptor_name":"Myasthenia Gravis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009157","descriptor_name":"Myasthenia Gravis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051056","descriptor_name":"Complement Inactivating Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D051056","descriptor_name":"Complement Inactivating Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1906981","doi":"https://doi.org/10.3389/fimmu.2026.1906981","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1906981","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1906981/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13683607","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13683607/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13683607/pdf/fimmu-17-1906981.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42908923","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42908923","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:0ea709e2db6042bf9474fb588ebfb20e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/0ea709e2db6042bf9474fb588ebfb20e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1906981","doi":"https://doi.org/10.3389/fimmu.2026.1906981","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1906981","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1906981/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220848616.pdf","grobid_xml":"https://content.openalex.org/works/W7220848616.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W315197452","https://openalex.org/W1969337370","https://openalex.org/W2014787563","https://openalex.org/W2017431273","https://openalex.org/W2030921111","https://openalex.org/W2057557618","https://openalex.org/W2066571580","https://openalex.org/W2109351747","https://openalex.org/W2137544340","https://openalex.org/W2138746931","https://openalex.org/W2142409409","https://openalex.org/W2154180887","https://openalex.org/W2325935826","https://openalex.org/W2554073739","https://openalex.org/W2895440324","https://openalex.org/W2912901461","https://openalex.org/W2918915582","https://openalex.org/W2954223196","https://openalex.org/W2965795186","https://openalex.org/W2982537032","https://openalex.org/W2989794488","https://openalex.org/W3004241310","https://openalex.org/W3011996040","https://openalex.org/W3042064122","https://openalex.org/W3047236488","https://openalex.org/W3094785429","https://openalex.org/W3106936335","https://openalex.org/W3138270687","https://openalex.org/W3170470841","https://openalex.org/W3177595832","https://openalex.org/W3201927313","https://openalex.org/W3210436931","https://openalex.org/W4200201076","https://openalex.org/W4206516299","https://openalex.org/W4231955763","https://openalex.org/W4283760813","https://openalex.org/W4294738847","https://openalex.org/W4321459014","https://openalex.org/W4367315646","https://openalex.org/W4399523739","https://openalex.org/W4400999916","https://openalex.org/W4401113255","https://openalex.org/W4405769542","https://openalex.org/W4409201096","https://openalex.org/W4409682209","https://openalex.org/W4415215107","https://openalex.org/W4416384261","https://openalex.org/W7118078571","https://openalex.org/W7138971595","https://openalex.org/W7142955787","https://openalex.org/W7164154319"],"related_works":["https://openalex.org/W4394622155","https://openalex.org/W4214814527","https://openalex.org/W4281766838","https://openalex.org/W4400999916","https://openalex.org/W7118562363","https://openalex.org/W4401113255","https://openalex.org/W7162328323","https://openalex.org/W4281632843","https://openalex.org/W3138507551","https://openalex.org/W1951143273"],"abstract_inverted_index":{"Introduction:":[0],"Eculizumab,":[1],"an":[2,308],"antibody":[3],"that":[4,241,276],"inhibits":[5],"the":[6,10,31,42,74,96,132,143,220,246,261],"complement":[7,227,249,287],"system,":[8],"and":[9,29,89,125,129,161,173,198,237,266,303,307],"immunosuppressant":[11],"Tacrolimus":[12,40,162,267,304],"are":[13],"both":[14,136,182],"authorized":[15],"for":[16],"treating":[17],"patients":[18,56,70,100,150,284],"with":[19,36,38,57,60,84,156,202,260,269,317,325],"generalized":[20,45],"myasthenia":[21,46],"gravis":[22],"(GMG).":[23],"This":[24],"study":[25,51],"seeks":[26],"to":[27,164],"evaluate":[28],"compare":[30],"clinical":[32,189,292],"effectiveness":[33],"of":[34,44,87,98,113,127,135,149,159,211,248,253,264,311,329,342],"Eculizumab":[35,61,78,88,160,165,172,242,265,270,277,302,318],"or":[37],"not":[39],"in":[41,65,73,111,188,196,206,226,235,282,294,315],"treatment":[43,137,183,306],"gravis.":[47],"Methods:":[48],"A":[49],"retrospective":[50],"was":[52,95,256],"performed":[53],"involving":[54],"95":[55],"GMG":[58,99,244,283,335],"treated":[59,83,155],"at":[62],"three":[63],"hospitals":[64],"China.":[66,295],"Among":[67],"them,":[68],"80":[69],"were":[71,82,139],"included":[72,109],"analysis:":[75],"57":[76],"received":[77],"alone,":[79],"while":[80],"23":[81],"a":[85,146,157,203,233,298,326],"combination":[86,158,262,305,321],"Tacrolimus.":[90],"The":[91,224],"main":[92,144],"outcome":[93,213],"assessed":[94],"percentage":[97],"who":[101],"reached":[102,151],"Minimal":[103],"Symptom":[104],"Expression":[105],"(MSE).":[106],"Secondary":[107],"outcomes":[108],"changes":[110],"MG-Activities":[112],"Daily":[114],"Living":[115],"(MG-ADL)":[116],"scale,":[117],"Quantitative":[118],"Myasthenia":[119],"Gravis":[120],"(QMG)":[121],"score,":[122],"CH50":[123,228],"concentration,":[124],"doses":[126],"pyridostigmine":[128],"prednisolone.":[130],"Additionally,":[131],"safety":[133],"profiles":[134],"groups":[138,184,222],"examined.":[140],"Results:":[141],"In":[142,251],"outcome,":[145],"higher":[147,327],"proportion":[148],"MSE":[152,313],"status":[153],"when":[154],"compared":[163],"alone":[166],"(Eculizumab:":[167],"29":[168],"patients,":[169,176,336],"50.9%":[170],"vs":[171],"Tacrolimus:":[174],"18":[175],"78.3%;":[177],"p<0.05).":[178],"Regarding":[179],"secondary":[180,212],"outcomes,":[181],"showed":[185],"significant":[186,204,217],"improvements":[187],"symptoms,":[190],"as":[191],"indicated":[192],"by":[193,232,285],"notable":[194],"reductions":[195],"QMG":[197,236],"MG-ADL":[199,238],"scores,":[200,239],"along":[201],"reduction":[205],"prednisolone":[207],"dosage.":[208],"Furthermore,":[209],"analysis":[210],"parameters":[214],"revealed":[215],"no":[216],"differences":[218],"between":[219,301],"two":[221],"(p>0.05).":[223],"decrease":[225,234],"concentration":[229],"is":[230,323],"accompanied":[231],"indicating":[240],"treats":[243],"through":[245],"mechanism":[247],"system.":[250],"terms":[252],"security,":[254],"hyperuricemia":[255],"more":[257],"commonly":[258],"associated":[259,324],"therapy":[263,322],"than":[268],"alone.":[271],"Conclusion:":[272],"Our":[273],"research":[274],"indicates":[275],"can":[278],"effectively":[279],"reduce":[280],"disability":[281],"inhibiting":[286],"system":[288],"activation":[289],"under":[290],"real-world":[291],"conditions":[293],"We":[296],"observed":[297],"correlative":[299],"link":[300],"increased":[309],"probability":[310],"achieving":[312],"status,":[314],"comparison":[316],"monotherapy.":[319],"However,":[320],"risk":[328],"elevated":[330],"serum":[331],"uric":[332],"acid":[333],"among":[334],"which":[337],"necessitates":[338],"regular":[339],"close":[340],"monitoring":[341],"renal":[343],"function.":[344]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-08T00:00:00"}